Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Principles of Science BVetMed 3 > Principles of anti-cancer drug therapy > Flashcards

Principles of anti-cancer drug therapy Flashcards

1
Q

Define chemotherapy

A

cytotoxic drugs used in cancer treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

When is chemotherapy indicated? 6

A
  1. ) Primary treatment for disseminated disease (lymphoma and other haematopoietic tumours)
  2. ) Adjuvant therapy following surgery for highly metastatic tumours
  3. ) In certain tumours following incomplete resection (microscopic residual disease) Also consider radiation
  4. ) Neo-adjuvant chemotherapy
  5. ) Treatment of chemosensitive tumours not amenable to surgery or radiation
  6. ) Primary treatment for TVT (vincristine)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Give some examples of tumours where adjuvant chemotherapy following surgery for highly metastatic tumours may be used.

A 
OSA
HSA
High grade STS
Grade 3 MCTs
Grade 2 MCT with high mitotic index
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When is chemo contraindicated?

A

when surgery or radiation treatment is a more effective alternative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How can chemo be administered?

A

COMMONLY - IV, PO, SC (drug-dependent)

OTHER: intracavitary (mesothelioma and caicnomatosis with 5-FU or carboplatin) or intralesional (rarely)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Define carcinomatosis

A

Where multiple carcinomas develop simultaneously, usually after dissemination from a primary source. It implies more than spread to regional nodes and even more than just metastatic disease. The term is usually taken to mean that there are multiple secondaries in multiple sites.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Define mesothelioma

A

cancer of cells that develop from the mesothelium which is the protective lining that covers the internal organs of the body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do chemo drugs work?

A

Interfere with cell growth or division
Can affect different stages of the cell cycle
Some drugs are cell cycle specific, others aren’t and can theoretically affect cells even in the resting (G0 phase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do vinca alkaloids work?

A

inhibit microtubule formation and interfere with the G2/M phase and anti-metabolites act in the S phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How do alkylating agents work?

A

not cell cycle specific (also anti-tumour antibiotics and platinum drugs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

When is chemo most likely to be effective?

A

when the disease burden is low (less effective for bulky disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When do you apply adjuvant chemotherapy?

A

following surgery, let the surgical wound heal (requires cell division) but then start chemo asap.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What does the cell kill hypothesis state?

A

that tumour cell kill follows first order kinetics (a given dose of cytotoxic drug will kill a fixed percentage of the tumour population as opposed to a set number of tumour cells. Will not completely eradicate the tumour)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Outline cytotoxic drug therapy

A 
Use at the MTD (--> highest fractional kill)
Multiple doses
Pulse doses (often used with carefully selected inter-dose intervals)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Is combination of single agent chemo usually more effective?

A

Combination (exceptions are vincristine in TVC and doxorubicin or carboplatin in OSA). Repeated use of a single agent is likely to select for resistant cells, whereas alternating drugs is less likely to cause selection pressure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the principles of combination chemo?

A

USE DRUGS THAT ARE:

  1. ) are effective against the tumour individually
  2. ) different modes of action and don’t interfere with each other’s action
  3. ) act on different stages of the cell cycle
  4. ) don’t have overlapping toxicities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What combination chemotherapy protocols are commonly used to treat lymphoma in dogs and cats?

A
  1. ) COP-based (cyclophosphamide, vincristine, prednisolone)
  2. ) Doxorubicin-containing protocols (CHOP) e.g. Wisconsin-Madison protocol
  3. ) Modified LOPP protocol for TC lymphoma (lomustine, vincristine, procarbazine, prednisolone)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How are cytotoxic chemotherapy drugs dosed?

A

MTD tends to correlate better with body surface area than body weight (and relates to metabolism). Most drugs are used on a mg/m2 basis.
BSA conversion charts
Obese animals - dose according to estimated lean body weight
Small dogs/cats - show increased toxicities when based on a mg/m2 basis - so dogs <10kg and cats are sometimes dosed on a mg/kg basis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the stages of chemotherapy?

A
  1. ) Induction
  2. ) Maintenance
  3. ) Re-induction
  4. ) Rescue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Name 2 alternatives to conventional cytotoxic chemotherpay

A
  1. ) Metronomic chemotherapy/ continuous low dose chemotherapy
  2. ) Receptor tyrosine kinase inhibitors (RTKIs)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Outline metronomic chemotherapy/continuous low dose chemotherapy

A

usually cytotoxic drug given alongside an NSAID
AIM = to slow growth by inhibiting angiongenesis via immunomodulatory effects, decreasing circulating Tregs and promoting anti-tumour immunity
No dramatic shrinkage, but stable disease/lack of progression.
Low dose cyclophosphamide most commonly
Similar survival times (canine HSA)
Can be used to delay time to recurrence in incompletely resected canine STS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Outline RTKIs

A

Interfere with aberrant signalling through cell surface receptors in cancer cells and have effects inhibiting angiogenesis, reducing proliferation and promoting apoptosis.
Dosed daily or EOD or MWF
Tumours may not shrink dramatically, but stable disease/lack of progression may be achieved
Toceranib and mastinib licensed for treatment of canine MCT.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

List what factors affect the success of anti-cancer drug therapy?

A

Tumour type
Penetration of drug into tumour
Development of drug resistance
Multi-drug resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What drugs are resistant/sensitive to anti-cancer drugs?

A

Highly sensitive - lymphoma

Relatively resistant - pancreatic and renal carcinomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
What does drug penetration into tumour depend on? 2
tumour blood supply and natural barriers
26
How does tumour drug resistance develop?
``` Various mechanisms: decreased drug uptake increased drug removal from cell decreased drug activation increased drug inactication increased/altered drug targets use of alternative pathways increased DNA repair ```
27
When does multi-drug resistance occur?
when tumour cells become cross-resistant to unrelated compounds
28
What is multi-drug resistance associated with?
increased expression of multi-drug resistance gene (MDR1), leading to increased p-glycoprotein (Pgp) expression, which pumps cytotoxic drugs such as vinca alkaloids and doxorubicin out of the cell. MDR1 gene can be activated by glucocorticoids and these drugs can induce resistance to vinca alkaloids/doxorubicin.
29
What should you do if resistance occurs?
switch to drugs that the tumour has not been exposed to before - preferably combinations of drugs with different mechanisms of action (rescue therapy)
30
What are AEs? | Give 4 examples
Adverse effects ``` EXAMPLES: Myelosuppression GIT toxicity Poor hair growth/whisker loss Drug extravasation ```
31
Outline myelosuppression due to cytotoxic drugs
``` BM haematopoietic SCs are affected by many anti-cancer drugs --> neutropenia and thrombocytopenia. Neutropenia = dose-limiting toxic effect of many agents Neutrophil nadir = drug-dependent, mostly at 7 days after dose (10-14 days for carboplatin) Platelet nadir = usually occurs 10 days post-treatment ```
32
How should myelosuppression be managed?
- Monitor CBCs regularly - take prior to administration of each potentially myelosuppressive drug. Delay treatment if neutrophil count is < 2*10^9/l or platelets <1*10^9/l but patient appears well, give prophylactic ABs (e.g. TMS) - If neutropenic and pyrexic/sick = URGENT! Give BS ABs (e.g. enrofloxacin and potentiated amoxicillin), barrier nurse, treat GI signs, IVFT.
33
What AEs hav a major effect on QoL?
``` GIT toxicity (must be prevented where possible) Risk of bacterial translocation exists (esp if neutropenic) ```
34
How should GIT toxicity AEs be managed? 3
VOMITING: bland diet, gut protectants (H2 blockers, sucralfate, omeprazole), anti-emetics (maropitant, odansetron) DIARRHOEA: bland diet, metronidazole for immunomodulatory effects (especially for colitis post-doxorubicin), possibly symptomatic tx (sulphasalazine, loperamide), IVFT (severe cases) ANOREXIA: maropitant if nauseous, appetite stimulants (cyproheptadine, mirtazapine), feeding tubes
35
How else can chemo drugs cause vomiting and nausea?
Direct action on the CRTZ EXAMPLES = platinum drugs (particularly cisplatin), dacarbazine, Actinomycin D, doxorubicin. Prophylactic anti-emetics should be given (maropitant, odansetron) prior to the chemo drug.
36
Outline hair loss due to chemo drugs
Complete alopecia is rare, but hair thinning/ slow regrowth post-clipping can occur. Extensive hair loss can occur in some breeds (OESD, Beardies, Poodles, some terriers)
37
Why is chemo drug extravasation undesirable?
Many of the IV chemo drugs are irritant or vesicant if extravasated (vincristine, vinblastine and doxorubin especially). = serious complication ,can result in severe tissue damage, even resulting in amputation so avoid!
38
Prevention - chemo drug extravasation
Cleanly placed IV catheter Tape in place securely Flush with saline (0.9%) before and after drug admin.
39
Treatment - chemo drug extravasation
Leave catheter in place and attempt to withdraw as much as possible (aspiration) Doxorubicin = apply ice packs, give dexrazoxane IV Vincristine = apply hot compress, inject hyaluronidase locally. Seek specialist advice Anti-inflammatory doses of dexamethasone IV and topical steroid creams might be useful, provided there are no other contraindications
40
Outline specific drug toxicities for DOXORUBICIN
Cardiotoxicity (dogs) Dysrhymthmias can occur during administration (rarely a problem if given slowl) Chronic toxicity - more significant, more likely to occur at cumulative doses >180,g/m^2 --> DCM Mast cell degranulation can occur (rare) during administration --> wheals, urticarial, puritis,oedema, V+D, dyspnoea or hypovolaemic shock. Nephrotoxicity (cats) Vesicant - if injected perivascularly GI - colitis
41
Outline specific drug toxicities for CYCLOPHOSPHAMIDE
haemorrhagic cystitis (dogs, v rare in cats) - the metabolite acrolein is irritant to the bladder lining.
42
What is oxybutinin? Use?
an anti-spasmodic | may be given in cases of cyclophosphamide toxicity induced haemorrhagic cystitis
43
Outline specific drug toxicities for VINCRISTINE - 3
- Peripheral neuropathies (interference with microtubule formation) - Ileus/constipation (cats) - Skin sloughs (perivascular administration)
44
Outline specific drug toxicities for LOMUSTINE
Hepatotoxicity (especially dogs) | Nephrotoxicity
45
Outline specific drug toxicities for PLATINUM DRUGS
Nephrotoxic (especially cisplatin) Vomiting (cisplatin, via CTZ) Carboplatin (preferable) Irritant (perivascular administration)
46
Outline specific drug toxicities in cats
DO NOT GIVE: Cisplatin --> fatal pulmonary oedema 5-FU --> extreme neurotoxicity
47
Outline specific drug toxicities in herding dog breeds
Increased sensitivity to vinca alkaloids (e.g. vincristine) and doxorubicin. EXAMPLES = collies, shetland sheepdogs, australian sheepdogs, long haired whippets WHY = mutation in MDR1 gene --> impaired excreteion Homozygotes worse than heterozygotes Use substrates that don't go via the pump such as cyclophosphamide and prednisolone for lymphoma.
48
Mechanism of action - ALKYLATING AGENTS Cell cycle specific? Examples
They substitute an alkyl group for a H+ ion in the DNA causing cross-linkage and breaking of DNA strands --> interference with DNA replication and transpriction. NOT cell cycle specific. EXAMPLES = cyclophosphamide, lomustine, melphalan,chlorambucil, procarbazine, dacarbazine
49
Mechanism of action - MITOTIC SPINDLE INHIBITORS Cell cycle specific? Examples
Bind to tubulin and prevent normal assembly of the microtubules. Causes arrest of mitosis in metaphase. YES cell cycle specific - affects G2/M phase EXAMPLES = vincristine, vinblastine, vinorelbine, taxanes (e.g. paclitaxel)
50
Mechanism of action - ANTI METABOLITES Cell cycle specific? Examples
Mimic normal substrates used in nucleic acid metabolism - either inhibit enzymes OR lead to the production of non-functional molecules, thus interfereing with DNA synthesis. YES cell cycle specific EXAMPLES = cytosine arabinsoide/cytarabine, methotrexate, hydroxycarbamide (hydroxyurea), 5-FU, gemcitabine, azathioprine
51
Mechanism of action - ANTI TUMOUR ANTIBIOTICS Cell cycle specific? Examples
Several mechanisms of action to prevent DNA and RNA synthesis: Inhibition of topoisomerase 2 (helps untangle DNA) Breaking of DNA strands Cross-linking of DNA base pairs Free radical oxidative damage (Doxorubicin) NOT cell cycle spefic EXAMPLES = doxorubicin, epirubicin mitoxantrone, actinomycin-D
52
Mechanism of action - PLATINUM COMPOUNDS Cell cycle specific? Examples
Work similarly to alkylating agents - the platnium compound causes inter and intrastrand crosslinks in the DNA, interfering with DNA synthesis and trasncription YES cell cycle specific EXAMPLES = carboplatin, (cisplatin)
53
Mechanism of action - CORTICOSTEROIDS Cell cycle specific? Examples Adverse effects
Not classed as a cytotoxic drug. Cause apoptosis of lymphoid and mast cells. NOT cell cycle specific EXAMPLES = prednisolone, dexamethasone ADVERSE EFFECTS: PD, PU, polpyphagia, excessive panting, mm weakness, slow wound healing, immunosuppression
54
Mechanism of action - L-ASPARAGINASE USE? Adverse effects.
Enzyme that breaks down L-asparagine USE = Tx of lymphoma/leukaemia since neoplastic lymphoid cells can't sythesise L-asparagine (lack L-aspargine synthetase), rely on an extracellular supply for protein synthesis and die in the presence of L-asparaginase. Normal cells can synthesise L-Asparagine de novo. ADVERSE EFFECTS = L-asaparaginase is a foreign protein --> possible allergic/anaphylactic reactions. Give anti-histamine prior to a second dose. Treat AEs with antihistmaine/dexamethasonne IV. Expensive.
55
How do NSAIDs work?
Anti-cancer effects are incompletely understood - they are thought to involve COX-2 inhibition. Inhibit angiogenesis, promote apoptosis, anti-inflammatory, analgesic EXAMPLES = prioxicam, meloxicam, firocoxib USE = in continuous low dose chemotherapy protocols/ metronomuc protocols, often alongside low dose cyclophosphamide. For the Tx of many tumours (TCC of bladder, prostate carcinoma) AE = gastric ulceration, renal toxicity
56
Define RTKI
Receptor Tyrosine Kinase Inhibitor
57
RTKI - mechanism of action Examples Adverse effects
MECHANISM: interfere with cell-signalling through cell-surface receptors known as RTKs, which are normallu involved in cell growth, proliferation and survival. Cancer cells may overexpress TKs (--> amplified signalling) or may carry a genetic mutation --> aberrant receptors that are consititutively activated. EXAMPLES = 2 drugs licencsed for treatment of non-resectable/metastatic grade 2 or 3 canine MCTs = mastinib and toceranib. Inhibit signalling through KIT receptors. About 40% canine MCTs have KIT mutations but these drugs are also effective in MCTs without KIT. ALso have effects through other RTKs ADVERSE EFFECTS = GIT effects common (V, D, weight loss, sometimes GI haemorrhage), myelosuppression (usually mild), proteinuria. ALso with toceranib --> mm cramping and hypertension. Depigmentation can occur.
58
Outline common drug indications - lymphoma
Vincristine, Cyclophosphamide, Prednisolone, Doxorubicin (lomustine/vinc/procarb/pred for canine TC lymphomas) Multi-agent therapy is 1st line of treatment (COP or CHOP for BC). Median survival is 1 year for multicentric high grade BC lymphoma in dogs (shorter for high grade TC).
59
Outline common drug indications - multiple myeloma
Melphalan and prednisolone (dogs) Chlorambucil and pred (cats) MST - approx 18 months in dogs, poorer in cats
60
Outline common drug indications - chronic lymphocytic leukaemia
Chlorambucil +pred (+/- vincristine) | MST - 1 year
61
Outline common drug indications - OSA
Carboplatin or doxorubicin (cisplatin) Adjuvant chemotherapy significantly increases survival after amputation (few moths with surgery alone, to 8-11 months)
62
Outline common drug indications - HSA
Doxorubicin single agent OR combined with cyclophosphamide (AC) +/- vincristine (VAC) Metronomic cyclophos + NSAID Adjuvant chemo significantly increases MST after splenectomy from 3 to 6 months. Also useful with metastases.
63
Outline common drug indications - MCT (high grade or metastatic)
``` Vinblastine/lomustine + pred Vinblastine _ cyclophos + pred Chlorambucil + pred Mastinib Toceranib ``` Used in adjuvant setting following surgery or radiotherapy or sometimes as sole therapy for high grade tumours. Mastinib - licensed for non-resectable grade 2 or 3 KIT mutation + MCT, Toceranib - non-resectable metastatic recurrent grade 2/3
64
Outline common drug indications - TCC of bladder/urethra
``` NSAIDs alone Metronomic chloramb. + NSAID Mitoxantrone + NSAID Vinblastine Carboplatin Gemcitabine Doxorubicin ``` Complete responses are rare - PR or stable disease more common, drug therapy improves clinical signs and prolongs survival.
65
Outline common drug indications - anal sac carcinoma
``` Carboplatin Melphalan Mitoxntrone Toceranib Metronomic therapy ``` Can be used as adjunctive therapy +/- radiation as first line treatments
66
Outline common drug indications - mammary carcinoma
Doxorubicin +/- cyclophosphamide (AC) - can be used in the adjuvant setting in cats or in gross disease. FAC in dogs (5-FU, doxorubicin, cyclophosphamide) - limited evidence for efficacy in dogs
67
Outline common drug indications - thyroid carcinoma (dogs)
Doxorubicin - adjuvant to surgery
68
Outline common drug indications - polycythaemia ver
Hyrdoxycarbamide/hydroxyurea | Survival often > 1 year
69
Outline common drug indications - histiocytic sarcoma
lomustine - sole therapy in disseminated disease or as adjunct to surgery.

Principles of Science BVetMed 3 (110 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions